Jazz Pharmaceuticals (JAZZ) Inventory (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Inventory of $437.5 million for Q1 2026, down 11.22% year-over-year from $492.8 million in Q1 2025, and up 4.92% quarter-over-quarter from $417.0 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Inventory (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Inventory history runs 17 years deep, the most recent figure standing at $437.5 million for Q1 2026.
- In Q1 2026, Inventory fell 11.22% year-over-year to $437.5 million; the TTM figure through Mar 2026 stood at $437.5 million (down 11.22% YoY), while the FY2025 annual figure was $417.0 million, down 13.21% from the prior year.
- Inventory for Q1 2026 stood at $437.5 million, up from $417.0 million in the prior quarter.
- The five-year high for Inventory was $985.5 million in Q1 2022, with the low at $417.0 million in Q4 2025.
- The 5-year median for Inventory is $577.3 million (2024), against an average of $606.2 million.
- Peak annual rise in Inventory reached 753.39% in 2022, while the deepest fall reached 36.01% in 2022.
- Jazz Pharmaceuticals' Inventory stood at $714.1 million in 2022, then slipped by 16.39% to $597.0 million in 2023, then decreased by 19.53% to $480.4 million in 2024, then slipped by 13.21% to $417.0 million in 2025, then advanced by 4.92% to $437.5 million in 2026.
- Business Quant data shows JAZZ's Inventory at $437.5 million in Q1 2026, $417.0 million in Q4 2025, and $483.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 443.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 443.00 Mn |
| Mar 31, 2026 | 437.50 Mn |
| Dec 31, 2025 | 417.00 Mn |
| Sep 30, 2025 | 483.11 Mn |
| Jun 30, 2025 | 504.99 Mn |
| Mar 31, 2025 | 492.78 Mn |
| Dec 31, 2024 | 480.45 Mn |
| Sep 30, 2024 | 539.30 Mn |
| Jun 30, 2024 | 542.56 Mn |
| Mar 31, 2024 | 577.32 Mn |
| Dec 31, 2023 | 597.04 Mn |
| Sep 30, 2023 | 611.83 Mn |
| Jun 30, 2023 | 657.21 Mn |
| Mar 31, 2023 | 674.78 Mn |
| Dec 31, 2022 | 714.06 Mn |
| Sep 30, 2022 | 728.07 Mn |
| Jun 30, 2022 | 861.71 Mn |
| Mar 31, 2022 | 985.45 Mn |
| Dec 31, 2021 | 1.07 Bn |
| Sep 30, 2021 | 1.14 Bn |